Murex Diagnostics UK subsidiary enters liquidation
This article was originally published in Clinica
Murex Diagnostics (UK) has been forced into voluntary liquidation by a UK High Court ruling that it must post a £6 million interim security for infringement of Chiron's UK hepatitis C patent. The amount was more than the assets of the UK subsidiary of International Murex. The interim cash security, payable to Chiron and Ortho Diagnostics within seven days of the February 16th ruling, is not a final judgement on infringement damages which will be determined at a full enquiry in July (see Clinica No 680, p 16).